Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase IV study of transdermal buprenorphine in elderly patients with chronic non-cancer pain
2007-000483-25Phase 4Active
- Sponsor
- Ospedale Israelitico
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of buprenorphine in Chronic non-cancer pain (CNCP), sponsored by Ospedale Israelitico. Primary endpoints: Pain intensity, Cognitive status and 6 more. Started Apr 2007; status: active.
02
Drugs
buprenorphine
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on 2007-000483-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000483-25.